The role of Tregs and CD11c+ macrophages/dendritic cells in ischemic preconditioning of the kidney

Kidney International

Volumn 78, Issue 10, 2010, Pages 981-992

  Cho, Won Yong ^a   Choi, Hye Min ^a   Lee, So Young ^b   Kim, Myung Gyu ^a   Kim, Hyoung Kyu ^a   Jo, Sang Kyung ^a  

^a Korea University College of Medicine   (South Korea)

^b Eulji University School of Medicine   (South Korea)

Author keywords

dendritic cell; immune cell; ischemic preconditioning; liposome clodronate; regulatory T cell

Indexed keywords

CLODRONIC ACID; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 6; LIPOSOME; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; IMMUNE DYSREGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; ISCHEMIC PRECONDITIONING; KIDNEY INJURY; KIDNEY ISCHEMIA; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SHAM PROCEDURE; SPLEEN CELL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION;

EID: 78049463266     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.266     Document Type: Article

References (33)

1. Park KM, Chen A, Bonventre JV. Prevention of kidney ischemia/ reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 2001; 276: 11870-11876.
2. Jancsó G, Cserepes B, Gasz B et al. Expression and protective role of heme oxygenase-1 in delayed myocardial preconditioning. Ann NY Acad Sci 2007; 1095: 251-261.
3. Eberlin KR, McCormack MC, Nguyen JT et al. Ischemic preconditioning of skeletal muscle mitigates remote injury and mortality. J Surg Res 2008; 148: 24-30.
4. Hausenloy DJ, Yellon DM. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res 2008; 79: 377-386 (review).
5. Przyklenk K, Bauer B, Ovize M et al. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993; 87: 893-899.
6. Takagi H, Manabe H, Kawai N et al. Review and meta-analysis of randomized controlled clinical trials of remote ischemic preconditioning in cardiovascular surgery. Am J Cardiol 2008; 102: 1487-1488 (review).
7. Cheung MM, Kharbanda RK, Konstantinov IE et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006; 47: 2277-2282.
8. Kharbanda RK, Mortensen UM, White PA et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 2002; 106: 2881-2883.
9. Hausenloy DJ, Yellon DM. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res 2008; 79: 377-386 (review).
10. Burne-Taney MJ, Liu M, Baldwin WM et al. Decreased capacity of immune cells to cause tissue injury mediates kidney ischemic preconditioning. J Immunol 2006; 176: 7015-7020.
11. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
12. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21: 685-711.
13. Park KM, Byun JY, Kramers C et al. Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 2003; 278: 27256-27266.
14. Offner H, Vandenbark AA, Hurn PD. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 2009; 158: 1098-1111.
15. Konstantinov IE, Arab S, Kharbanda RK et al. The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiol Genomics 2004; 19: 143-150.
16. McGeachy MJ, Stephens LA, Anderton SM. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J Immunol 2005; 175: 3025-3032.
17. Erhardt A, Biburger M, Papadopoulos T et al. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 2007; 45: 475-485.
18. Li W, Carper K, Zheng XX et al. The role of Foxp3+ regulatory T cells in liver transplant tolerance. Transplant Proc 2006; 38: 3205-3206.
19. Tang Q, Bluestone JA. Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 2006; 212: 217-237 (review).
20. Feng G, Wood KJ, Bushell A. Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy. Transplantation 2008; 86: 578-589.
21. Kinsey GR, Sharma R, Huang L et al. Regulatory T cells suppress innate immunity in kidney ischemia/reperfusion injury. J Am Soc Nephrol 2009; 20: 1744-1753.
22. Gandolfo MT, Jang HR, Satpute S et al. Foxp3 regulatory T cells participate in repair from kidney ischemia reperfusion injury. Kidney Int 2009; 76: 717-729.
23. van Mierlo GJ, Scherer HU, Hameetman M et al. Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators. J Immunol 2008; 180: 2747-2751.
24. Taams LS, van Amelsfort JM, Tiemessen MM et al. Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum Immunol 2005; 66: 222-230.
25. Maloy KJ, Salaun L, Cahill R et al. CD4+CD25+ TR cells suppress innate immune pathology through cytokine dependent mechanisms. J Exp Med 2003; 197: 111-119.
26. Vlad G, Cortesini R, Suciu-Foca N. License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. J Immunol 2005; 174: 5907-5914.
27. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002; 23: 445-449.
28. Yamazaki S, Iyoda T, Tarbell K et al. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 2003; 198: 235-247.
29. Rutella S, Danese S, Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 2006; 108: 1435-1440.
30. Chorny A, Gonzalez-Rey E, Fernandez-Martin A et al. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. Proc Natl Acad Sci USA 2005; 102: 13562-13567.
31. Menges M, Rö ssner S, Voigtländer C et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 2002; 195: 15-21.
32. Jang HS, Kim J, Park YK et al. Infiltrated macrophages contribute to recovery after ischemic injury but not to ischemic preconditioning in kidneys. Transplantation 2008; 85: 447-455.
33. + cells impairs the recovery process in ischaemia/reperfusion- induced acute kidney injury. Nephrol Dial Transplant; e-pub ahead of print 12 April 2010.